4Gilbert SO. The human proteome organization plasma proteome project pilot phase: reference specimens, technology platform comparisons, and standardized data submission and analysis. Proteomics, 2004,4 : 1235-1240.
5Petricoin EF, Ardekani AM, Hitt BA: et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet,2002,359:572-577.
6Adam BL, Qu Y, Davis JW. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res, 2002, 62:3609-3614.
7Keith AB, Jeffery SMI Kevin K, et al. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics, 2004,20 : 777-796.
8Orchard S, Hemjakob H,Apweiler R. The proteomic standards mitaitive. Proteomics, 2003, 3 : 2065-2066.
9Alexe G, Alexe S, Liotta LA, et al. Ovarian cancer detection by logical analysis of proteomics data. Proteomics,2002, 2: 1-38.
10Semmes OJ, Feng ZD, Adam BL, et al. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer I. Assessment of Platform Reproducibility. Clin Chem, 2005, 51 : 102-112.
